NICE recommends more genetic testing for links to ovarian cancer
Around 340,000 to 444,000 people in the UK carry one of nine pathogenic gene variants
Read More
Tag: The National Institute for Health and Care Excellence
Pfizer’s Vydura recommended by NICE for acute migraines
The treatment is the first oral GPCR receptor antagonist class recommended for NHS use
Read More
NICE updates hypertension guideline
The clinical management of hypertension accounts for 12% of visits to primary care and up to £2.1 billion of healthcare expenditure.
Read More
NICE highlights need for more cannabis-based research
NHS England has also published a review aimed at assessing the barriers to prescribing cannabis-based medicinal products.
Read More
AZ to appeal NICE rejection for lung cancer drug
The committee didn’t OK the drug as the cost effectiveness estimates were above what NICE normally considers to be an acceptable use of NHS resources.
Read More
NICE publishes draft guidance on adult leg ulcers
Overuse of antimicrobials is contributing to a global threat of worldwide antimicrobial resistance.
Read More
Report finds NICE’s routine appraisals need reform
A report by MAP BioPharma has found that NICE’s appraisal of rare disease medicines does not deliver equal access for patients.
Read More
NICE endorsement means more donor livers could be used for transplantation
The National Institute for Health and Care Excellence has announced that an “exciting development” could increase the number of livers which can be safely used for transplantation.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
